GW Pharma CEO: More education needed on real health benefits of drugs derived from cannabisCNBC • 08/07/19
GW Pharmaceuticals' (GWPH) CEO Justin Gover on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19
This Biotech Stock Flew Higher On Likely CBD Oil Approval in EuropeInvestors Business Daily • 07/26/19
European Medicines Agency gives positive opinion on GW Pharma's cannibidiol drugMarket Watch • 07/26/19
GW Pharmaceuticals PLC (GWPH) Gains But Lags Market: What You Should KnowZacks Investment Research • 07/24/19
Legal Cannabis Faces Competition from Black Market: 3 Stocks That Can Lead the BrigadeZacks Investment Research • 07/12/19